103 related articles for article (PubMed ID: 16506265)
1. Total activin A in maternal blood as a marker of preterm delivery in low-risk asymptomatic patients.
Farina A; Lambert-Messerlian GM; Canick JA; Banzola I; Carletti A; Concu M; Tempesta A; Gabrielli S; Morano D; Rizzo N
Prenat Diagn; 2006 Mar; 26(3):277-81. PubMed ID: 16506265
[TBL] [Abstract][Full Text] [Related]
2. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.
Spencer K; Cowans NJ; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Oct; 32(5):622-6. PubMed ID: 18816493
[TBL] [Abstract][Full Text] [Related]
3. First trimester levels of inhibins and activin A in normal and failing pregnancies.
Wallace EM; Marjono B; Tyzack K; Tong S
Clin Endocrinol (Oxf); 2004 Apr; 60(4):484-90. PubMed ID: 15049964
[TBL] [Abstract][Full Text] [Related]
4. First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction.
Ong CY; Liao AW; Munim S; Spencer K; Nicolaides KH
J Matern Fetal Neonatal Med; 2004 Mar; 15(3):176-80. PubMed ID: 15280143
[TBL] [Abstract][Full Text] [Related]
5. Performance of a panel of maternal serum markers in predicting preeclampsia at 11-15 weeks' gestation.
Banzola I; Farina A; Concu M; Sekizawa A; Purwosunu Y; Strada I; Arcelli D; Simonazzi G; Caramelli E; Rizzo N
Prenat Diagn; 2007 Nov; 27(11):1005-10. PubMed ID: 17654753
[TBL] [Abstract][Full Text] [Related]
6. Maternal serum activin A and the prediction of intrauterine growth restriction.
Barkehall-Thomas A; Tong S; Baker LS; Edwards A; Wallace EM
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):97-101. PubMed ID: 16638029
[TBL] [Abstract][Full Text] [Related]
7. Uterine vein and maternal urinary levels of activin A and inhibin A in pre-eclampsia patients.
Muttukrishna S; Hyett J; Paine M; Moodley J; Groome N; Rodeck C
Clin Endocrinol (Oxf); 2006 Apr; 64(4):469-73. PubMed ID: 16584522
[TBL] [Abstract][Full Text] [Related]
8. Concentrations of serum total activin A and inhibin A in preterm and term labor patients: a cross-sectional study.
Plevyak MP; Lambert-Messerlian GM; Farina A; Groome NP; Canick JA; Silver HM
J Soc Gynecol Investig; 2003 May; 10(4):231-6. PubMed ID: 12759152
[TBL] [Abstract][Full Text] [Related]
9. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery.
Spencer K; Cowans NJ; Molina F; Kagan KO; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Feb; 31(2):147-52. PubMed ID: 17992705
[TBL] [Abstract][Full Text] [Related]
10. Maternal serum activin A levels in association with intrauterine fetal growth restriction.
Wallace EM; Schneider-Kolsky ME; Edwards A; Baker L; Jenkin G
BJOG; 2003 Mar; 110(3):306-10. PubMed ID: 12628273
[TBL] [Abstract][Full Text] [Related]
11. Maternal serum ferritin concentration in patients with preterm labor and intact membranes.
Weintraub AY; Sheiner E; Mazor M; Levy A; Tevet A; Paamoni O; Wiznitzer A
J Matern Fetal Neonatal Med; 2005 Sep; 18(3):163-6. PubMed ID: 16272038
[TBL] [Abstract][Full Text] [Related]
12. Adhesion molecules, activin and inhibin--candidates for the biochemical prediction of hypertensive diseases in pregnancy?
Hanisch CG; Pfeiffer KA; Schlebusch H; Schmolling J
Arch Gynecol Obstet; 2004 Sep; 270(2):110-5. PubMed ID: 12898146
[TBL] [Abstract][Full Text] [Related]
13. Activin A, hypoxia and the prediction of obstetric outcomes.
Tong S
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):146-7. PubMed ID: 16638038
[TBL] [Abstract][Full Text] [Related]
14. Inhibin A and activin A may be used to predict pregnancy outcome in women with recurrent miscarriage.
Prakash A; Laird S; Tuckerman E; Li TC; Ledger WL
Fertil Steril; 2005 Jun; 83(6):1758-63. PubMed ID: 15950648
[TBL] [Abstract][Full Text] [Related]
15. Corticotropin-releasing hormone, corticotropin-releasing hormone-binding protein, and activin A in maternal serum: prediction of preterm delivery and response to glucocorticoids in women with symptoms of preterm labor.
Coleman MA; France JT; Schellenberg JC; Ananiev V; Townend K; Keelan JA; Groome NP; McCowan LM
Am J Obstet Gynecol; 2000 Sep; 183(3):643-8. PubMed ID: 10992187
[TBL] [Abstract][Full Text] [Related]
16. Prediction of preterm delivery using changes in serum relaxin in low risk pregnancies.
Vogel I; Thorsen P; Hundborg HH; Uldbjerg N
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):113-8. PubMed ID: 16337329
[TBL] [Abstract][Full Text] [Related]
17. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
[TBL] [Abstract][Full Text] [Related]
18. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
19. Umbilical cord serum activin A levels are increased in pre-eclampsia with impaired blood flow in the uteroplacental and fetal circulation.
Florio P; Reis FM; Severi FM; Luisi S; Imperatore A; Palumbo MA; Bagnoli F; Gioffre W; Petraglia F
Placenta; 2006; 27(4-5):432-7. PubMed ID: 16051348
[TBL] [Abstract][Full Text] [Related]
20. [Study on the relationship between activin A, follistatin and preeclampsia].
Zhao L; Shang T; Wang YL; Tang S; Li H; Liu ZH
Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):676-9. PubMed ID: 14728855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
